Tag: FDA
Navigating Patent Potholes Along the FDA’s Proposed ANDA / 505(b)(2) Pathway
EVENT, Dec. 2, 9 a.m. PST
Fitch, Even, Tabin & Flannery LLP will present a free MCLE webinar, “Navigating Patent Potholes Along the FDA’s Proposed ANDA / 505(b)(2) Pathway,” on December 2, 2015, featuring Fitch Even attorneys Kendrew H. Colton and James A. Zak.
